PEPTONIC medical AB (publ) (XSAT:PMED)

PEPTONIC medical AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	14.79	26.89	37.12	43.63	31.64
Revenue Growth (YoY)	-45.01%	-27.55%	-14.93%	37.90%	48.68%
Cost of Revenue	4.84	11.73	20.82	20.24	12.57
Gross Profit	9.95	15.16	16.3	23.4	19.07
Selling, General & Admin	35.3	56.72	52.28	56.11	65.12
Other Operating Expenses	-11.65	-7.64	-1.06	-2.6	0.61
Operating Expenses	29.4	73.81	57.48	57	92.79
Operating Income	-19.45	-58.65	-41.19	-33.61	-73.72
Interest Expense	-3.09	-1.41	-2.32	-5.56	-0.07
Interest & Investment Income	0.05	0.03	0.92	2.31	0.1
Other Non Operating Income (Expenses)	0	-	0	-	-0
Pretax Income	-22.5	-60.03	-42.59	-36.86	-73.69
Net Income	-22.5	-60.03	-42.59	-36.86	-73.69
Net Income to Common	-22.5	-60.03	-42.59	-36.86	-73.69
Shares Outstanding (Basic)	8,425	3,600	1,535	243	192
Shares Outstanding (Diluted)	8,425	3,600	1,535	243	192
Shares Change (YoY)	134.00%	134.57%	532.29%	26.67%	17.63%
EPS (Basic)	-0.00	-0.02	-0.03	-0.15	-0.38
EPS (Diluted)	-0.00	-0.02	-0.03	-0.15	-0.38
Free Cash Flow	-	-37.56	-34.45	-40.22	-43.36
Free Cash Flow Per Share	-	-0.01	-0.02	-0.17	-0.23
Gross Margin	67.31%	56.38%	43.90%	53.62%	60.27%
Operating Margin	-131.52%	-218.10%	-110.96%	-77.02%	-232.97%
Profit Margin	-152.12%	-223.23%	-114.74%	-84.47%	-232.87%
Free Cash Flow Margin	-	-139.66%	-92.82%	-92.17%	-137.04%
EBITDA	-17.52	-56.4	-39.62	-32.91	-49.61
EBITDA Margin	-118.46%	-209.72%	-106.75%	-75.41%	-156.78%
D&A For EBITDA	1.93	2.25	1.56	0.7	24.11
EBIT	-19.45	-58.65	-41.19	-33.61	-73.72
EBIT Margin	-131.52%	-218.10%	-110.96%	-77.02%	-232.97%
Revenue as Reported	26.75	27.62	38.27	46.4	32.27

Source: S&P Global Market Intelligence. Standard template. Financial Sources.